Showing results (1-10 of 430) with videos related to

Sort By:
Pageof 43
Oncology Research and Treatment|July 11, 2017
Circulating Tumor Cells in Esophageal CancerJens Hoeppner, Birte Kulemann
Surgical Endoscopy|January 2, 2014
Covered self-expanding stent treatment for anastomotic leakage: outcomes in esophagogastric and esophagojejunal anastomosesJens Hoeppner, Birte Kulemann, Garbriel Seifert, et al.
Journal of Clinical Medicine|July 10, 2019
Hybrid Minimally Invasive Esophagectomy-Surgical Technique and ResultsJasmina Kuvendjiska, Goran Marjanovic, Torben Glatz, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|October 30, 2016
Management and outcome of esophageal stenting for spontaneous esophageal perforationsTorben Glatz, Goran Marjanovic, Birte Kulemann, et al.
ANZ Journal of Surgery|December 20, 2019
Short-term and long-term outcomes of oesophagogastric surgery for cancer in obese and normal weight patientsTorben Glatz, Birte Kulemann, Jasmina Kuvendjiska, et al.
World Journal of Gastrointestinal Surgery|March 22, 2013
Limited resection for duodenal gastrointestinal stromal tumors: Surgical management and clinical outcomeJens Hoeppner, Birte Kulemann, Goran Marjanovic, et al.
Cancers|November 14, 2019
Circulating Tumor Cells in Pancreatic Cancer: Current PerspectivesVerena Martini, Sylvia Timme-Bronsert, Stefan Fichtner-Feigl, et al.
BMC Surgery|January 15, 2017
Postoperative fluid overload is a risk factor for adverse surgical outcome in patients undergoing esophagectomy for esophageal cancer: a retrospective study in 335 patientsTorben Glatz, Birte Kulemann, Goran Marjanovic, et al.
Langenbeck'S Archives of Surgery|January 14, 2017
Hybrid minimally invasive esophagectomy vs. open esophagectomy: a matched case analysis in 120 patientsTorben Glatz, Goran Marjanovic, Birte Kulemann, et al.
Journal of Clinical Medicine|August 23, 2020
Pattern of Recurrence and Patient Survival after Perioperative Chemotherapy with 5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) for Locally Advanced Esophagogastric Adenocarcinoma in Patients Treated Outside Clinical TrialsTorben Glatz, Rasmus Verst, Jasmina Kuvendjiska, et al.
Pageof 43